Table of Content




1. Executive Summary


2. Global Post-Traumatic Stress Disorder (PTSD) Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Post-Traumatic Stress Disorder (PTSD) Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
3.3.1: Antidepressants
3.3.2: Cognitive Therapy
3.3.3: Anti-Anxiety Drugs
3.3.4: Exposure Therapy
3.3.5: Eye Movement Desensitization & Reprocessing (EMDR)
3.3.6: PSTD therapeutics

3.4: Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
3.4.1: Children
3.4.2: Adult

3.5: Global Post-Traumatic Stress Disorder (PTSD) Market by End Use
3.5.1: Hospitals
3.5.2: Clinics





4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Post-Traumatic Stress Disorder (PTSD) Market by Region
4.2: North American Post-Traumatic Stress Disorder (PTSD) Market
4.2.1: North American Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
4.2.2: North American Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics

4.3: European Post-Traumatic Stress Disorder (PTSD) Market

4.3.1: European Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
4.3.2: European Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics

4.4: APAC Post-Traumatic Stress Disorder (PTSD) Market

4.4.1: APAC Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
4.4.2: APAC Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics

4.5: ROW Post-Traumatic Stress Disorder (PTSD) Market

4.5.1: ROW Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
4.5.2: ROW Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
6.1.2: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
6.1.3: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by End Use

6.1.4: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Region

6.2: Emerging Trends in the Global Post-Traumatic Stress Disorder (PTSD) Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Post-Traumatic Stress Disorder (PTSD) Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Post-Traumatic Stress Disorder (PTSD) Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: GlaxoSmithKline
7.2: Pfizer
7.3: Eli Lilly & Company
7.4: Azevan Pharmaceuticals
7.5: Otsuka Pharmaceutical
7.6: AstraZeneca
7.7: Neurocrine Biosciences
7.8: Nuvo Pharmaceuticals
7.9: Marinus Pharmaceuticals
7.10: Tonix Pharmaceuticals